KR880009647A - 우울증 치료 활성을 갖는 제제 - Google Patents

우울증 치료 활성을 갖는 제제 Download PDF

Info

Publication number
KR880009647A
KR880009647A KR1019880001966A KR880001966A KR880009647A KR 880009647 A KR880009647 A KR 880009647A KR 1019880001966 A KR1019880001966 A KR 1019880001966A KR 880001966 A KR880001966 A KR 880001966A KR 880009647 A KR880009647 A KR 880009647A
Authority
KR
South Korea
Prior art keywords
agent
hydrogen
formulation
group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019880001966A
Other languages
English (en)
Korean (ko)
Inventor
레어 에리히
베흐텔 볼프-디이트리히
슈스터 아스트리트
Original Assignee
디이터 라우디엔, 루돌프 호프만
베링거 인겔하임 케이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디이터 라우디엔, 루돌프 호프만, 베링거 인겔하임 케이지 filed Critical 디이터 라우디엔, 루돌프 호프만
Publication of KR880009647A publication Critical patent/KR880009647A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)
  • Pyrrole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019880001966A 1987-02-27 1988-02-26 우울증 치료 활성을 갖는 제제 Ceased KR880009647A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873706399 DE3706399A1 (de) 1987-02-27 1987-02-27 Mittel mit antidepressiver wirkung
DEP3706399.5 1987-02-27

Publications (1)

Publication Number Publication Date
KR880009647A true KR880009647A (ko) 1988-10-04

Family

ID=6321945

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880001966A Ceased KR880009647A (ko) 1987-02-27 1988-02-26 우울증 치료 활성을 갖는 제제

Country Status (14)

Country Link
US (2) US4931435A (cg-RX-API-DMAC10.html)
EP (1) EP0280290B1 (cg-RX-API-DMAC10.html)
JP (1) JPS63238019A (cg-RX-API-DMAC10.html)
KR (1) KR880009647A (cg-RX-API-DMAC10.html)
AT (1) ATE71300T1 (cg-RX-API-DMAC10.html)
AU (1) AU605554B2 (cg-RX-API-DMAC10.html)
CA (1) CA1317229C (cg-RX-API-DMAC10.html)
DE (2) DE3706399A1 (cg-RX-API-DMAC10.html)
DK (1) DK102988A (cg-RX-API-DMAC10.html)
GR (1) GR3003657T3 (cg-RX-API-DMAC10.html)
HU (1) HU200919B (cg-RX-API-DMAC10.html)
IL (1) IL85560A (cg-RX-API-DMAC10.html)
NZ (1) NZ223670A (cg-RX-API-DMAC10.html)
ZA (1) ZA881366B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000051610A1 (en) * 1999-03-02 2000-09-08 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6362201B1 (en) 1999-03-02 2002-03-26 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
WO2000051609A1 (en) * 1999-03-02 2000-09-08 Merck & Co., Inc. 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3301759A (en) * 1965-05-26 1967-01-31 Robins Co Inc A H Analeptic compositions and method
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
IL85560A0 (en) 1988-08-31
HUT46535A (en) 1988-11-28
EP0280290B1 (de) 1992-01-08
DE3706399A1 (de) 1988-09-08
NZ223670A (en) 1990-12-21
DE3867501D1 (de) 1992-02-20
HU200919B (en) 1990-09-28
EP0280290A2 (de) 1988-08-31
AU605554B2 (en) 1991-01-17
DK102988D0 (da) 1988-02-26
GR3003657T3 (cg-RX-API-DMAC10.html) 1993-03-16
CA1317229C (en) 1993-05-04
ZA881366B (en) 1989-10-25
JPS63238019A (ja) 1988-10-04
US5217967A (en) 1993-06-08
AU1235288A (en) 1988-09-01
ATE71300T1 (de) 1992-01-15
DK102988A (da) 1988-08-28
US4931435A (en) 1990-06-05
EP0280290A3 (en) 1989-08-09
IL85560A (en) 1991-12-12

Similar Documents

Publication Publication Date Title
BR0111754A (pt) Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica
KR940013501A (ko) 혈청 콜레스테롤을 저하시키는데 유용한 벤조티오펜
KR960701878A (ko) 수용성 캄프토테신 유도체, 이의 제조 방법 및 항종양제로서의 이의 용도(Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents)
KR930703303A (ko) 1, 4-벤조티아제핀 유도체
KR880012227A (ko) 도파민 수용체 길항제의 신규사용법
KR890012970A (ko) 테트라히드로 이소퀴놀린 유도체
KR960007592A (ko) 신규한 피롤로카바졸
AU643290B2 (en) Derivatives of 2-aminoalkyl-5-arylalkyl-1,3-dioxanes, their preparation and their therapeutic application
KR910009672A (ko) 피리다진 유도체, 이의 제조방법 및 이것을 함유하는 약학 조성물
ATE34753T1 (de) Derivate von pristinamycin iib, deren herstellung und deren pharmazeutische zusammensetzungen.
KR880012586A (ko) 새로운 피리딜 및 피리미딜 유도체
FI945582A0 (fi) Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina
ATE170851T1 (de) Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten
DE69217613D1 (de) Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
MX9304403A (es) Derivados farmacologicamente activos de ó-(aminometilo terciario)-bencenmetanol
AR027035A1 (es) Pirroles sustituidos
ES2172436B1 (es) Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
KR890006234A (ko) 고혈압 및 심부전증 치료제
ES8800938A1 (es) Procedimiento para preparar derivados berbanicos biologicamente activos.
KR890017241A (ko) 신규의 1, 2-디티올-3-티온-s-옥사이드 화합물류를 함유한 약제
TR200000154T2 (tr) 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
KR880005077A (ko) 우울증 억제제로서 1-벤질-아미노알킬-피롤리디논의 용도
KR920002550A (ko) 6-알킬피리다진 유도체, 그의 제법 및 그를 함유하는 약학 조성물
KR890001538A (ko) 동물의 성장촉진제 조성물

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19880226

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19930225

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19880226

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19960326

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19960531

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19960326

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I